Sarepta 9001 Clinical Trial Updates

June 28, 2021

Sarepta has shared an update regarding several of their ongoing SRP-9001 clinical trials, which you can read here. They are working with regulators to finalize plans and will be communicating with the Duchenne community in further detail in upcoming months.

For any additional questions, please reach out to Advocacy@sarepta.com.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open